Financials Neptune Wellness Solutions Inc.

Equities

NEPTF

CA64079L3039

Pharmaceuticals

Market Closed - OTC Markets 02:58:19 2024-05-07 pm EDT 5-day change 1st Jan Change
0.022 USD -26.67% Intraday chart for Neptune Wellness Solutions Inc. -51.22% -95.87%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 221.4 255.1 111.3 216.9 41.78 6.36
Enterprise Value (EV) 2 201.8 248.7 99.44 159.8 47.39 29.66
P/E ratio 12.8 x -10.9 x -1.72 x -0.95 x -0.5 x -0.11 x
Yield - - - - - -
Capitalization / Revenue 8.01 x 10.4 x 3.76 x 4.63 x 0.86 x 0.12 x
EV / Revenue 7.3 x 10.2 x 3.36 x 3.41 x 0.97 x 0.56 x
EV / EBITDA -10.6 x -21 x -1.72 x -1.57 x -0.74 x -0.64 x
EV / FCF -52.7 x -73 x -4.44 x -3.67 x -1.29 x -1.9 x
FCF Yield -1.9% -1.37% -22.5% -27.3% -77.3% -52.7%
Price to Book 2.56 x 3.7 x 0.81 x 1.49 x 0.9 x -0.54 x
Nbr of stocks (in thousands) 56.3 57.1 67.9 118 134 294
Reference price 3 3,934 4,466 1,638 1,834 311.4 21.60
Announcement Date 6/5/18 6/12/19 6/10/20 7/15/21 7/7/22 7/17/23
1USD in Million2CAD in Million3USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 27.65 24.44 29.58 46.81 48.8 52.62
EBITDA 1 -18.99 -11.84 -57.68 -101.8 -63.9 -46.65
EBIT 1 -22.53 -14.88 -65.61 -125.4 -69.98 -49.38
Operating Margin -81.5% -60.89% -221.81% -267.88% -143.41% -93.86%
Earnings before Tax (EBT) 1 7.699 -23.02 -56.26 -173.2 -84.42 -88.8
Net income 1 17.53 -23.19 -60.86 -167.1 -74.97 -60.46
Net margin 63.41% -94.88% -205.77% -357.08% -153.64% -114.91%
EPS 2 308.0 -408.2 -952.0 -1,930 -621.6 -204.8
Free Cash Flow 1 -3.826 -3.405 -22.4 -43.58 -36.64 -15.64
FCF margin -13.84% -13.93% -75.73% -93.11% -75.09% -29.72%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 6/5/18 6/12/19 6/10/20 7/15/21 7/7/22 7/17/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 15.73 18.45 14.93 20.99 16.41 16.52 16.01 14.37
EBITDA 1 -9.486 -9.816 -35.32 -12.61 -18.68 -6.843 -17.08 -9.827
EBIT 1 -21.71 -21.12 -37.27 -18.57 -54.36 -9.555 -54.94 -9.807
Operating Margin -137.96% -114.52% -249.69% -88.45% -331.21% -57.84% -343.21% -68.24%
Earnings before Tax (EBT) 1 -13.96 -20.94 -48.6 -8.39 -51.04 -0.6704 -58.67 -8.655
Net income 1 -12.7 -18.66 -42.5 -8.39 -42.31 -0.6731 -35.01 -8.655
Net margin -80.75% -101.15% -284.7% -39.97% -257.76% -4.07% -218.7% -60.22%
EPS 2 -112.0 -154.0 -340.0 -56.24 -215.8 -2.427 -117.4 -16.26
Dividend per Share - - - - - - - -
Announcement Date 11/15/21 2/10/22 7/8/22 8/15/22 12/16/22 3/30/23 7/17/23 8/18/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 5.61 23.3
Net Cash position 1 19.6 6.4 11.8 57.1 - -
Leverage (Debt/EBITDA) - - - - -0.0878 x -0.4994 x
Free Cash Flow 1 -3.83 -3.41 -22.4 -43.6 -36.6 -15.6
ROE (net income / shareholders' equity) 11.6% -29.8% -57.3% -106% -85.1% -534%
ROA (Net income/ Total Assets) -13.4% -9.85% -31.7% -38.8% -30% -45.4%
Assets 1 -130.6 235.4 192.2 430.3 250.2 133.1
Book Value Per Share 2 1,537 1,207 2,024 1,235 347.0 -39.80
Cash Flow per Share 2 431.0 172.0 234.0 635.0 62.80 6.650
Capex 1 1.27 6.74 13.8 8.75 1.94 0.93
Capex / Sales 4.58% 27.57% 46.61% 18.69% 3.97% 1.77%
Announcement Date 6/5/18 6/12/19 6/10/20 7/15/21 7/7/22 7/17/23
1CAD in Million2CAD
Estimates
  1. Stock Market
  2. Equities
  3. NEPTF Stock
  4. Financials Neptune Wellness Solutions Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW